Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
First Claim
Patent Images
1. A composition for inhibiting bacterial biofilm on devices selected from the group comprising:
- (a) an iron-sequestering glycoprotein, a cationic polypeptide, and a chelating agent;
(b) an iron-sequestering glycoprotein and a cationic polypeptide; and
(c) an iron-sequestering glycoprotein and a chelating agent.
1 Assignment
0 Petitions
Accused Products
Abstract
A synergistic antimicrobial composition for inhibiting biofilm formation includes an iron-sequestering glycoprotein, a cationic polypeptide and a chelating agent, or an iron-sequestering glycoprotein and a chelating agent, or an iron-sequestering glycoprotein and a cationic polypeptide. Additionally, surfactants and quaternary ammonium compounds may also be advantageously combined with iron-sequestering glycoproteins in an antimicrobial composition. Methods of using a synergistic composition for inhibiting medical device biofilm formation are also disclosed.
51 Citations
34 Claims
-
1. A composition for inhibiting bacterial biofilm on devices selected from the group comprising:
-
(a) an iron-sequestering glycoprotein, a cationic polypeptide, and a chelating agent;
(b) an iron-sequestering glycoprotein and a cationic polypeptide; and
(c) an iron-sequestering glycoprotein and a chelating agent. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)
-
- 32. The composition of claim 32, wherein the composition is effective against biofilms produced by bacterial species selected from the group consisting of Staphylococcus epidermidis, Enterococcus faecalis, E. coli, Proteus mirabilis, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, Streptococcus viridans, Klebsiella oxytoca, Staphylococcus saprophyticus, Providentia stuartii and Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa and Staphylococcus epidermidis.
-
34. The composition of claim 58, wherein the composition is effective against biofilms produced by Staphylococcus epidermidis.
Specification